http://www.theheart.org/article/1434435.do?utm_medium=email&utm_source=20120903_TopTen&utm_campaign=newsletter
Statin users are more than 50% likelier to develop age-related cataracts, according to the results of a new study [1]. And type 2 diabetics who use statins are at even greater risk of cataracts, report investigators.
"The bioplausibility of these results lies in
the fact that the crystalline lens membrane requires high cholesterol
for proper epithelial cell development and lens transparency," write Dr Carolyn Machan (University of Waterloo, ON) and colleagues in the August 2012 issue of Optometry and Vision Science.
"Increased cataract formation has been seen in both animals and humans
with hereditary cholesterol deficiency, and the risk exists that statins
can inhibit cholesterol biosynthesis in the human lens."
Asked to comment on the paper for heartwire, Dr Richard Karas
(Tufts University School of Medicine, Boston, MA), called the findings
"an interesting observation [that] isn't alarmist." There is, he says, a
"suggestion" here that statins may increase the risk of cataracts, but
this visual problem eventually afflicts everyone of a certain age
anyhow, he says, adding that further study of this association will be
required.
Waterloo Eye Study includes almost 6500 patients
The analysis included 6397 patients with and
without diabetes. As the researchers note, diabetes is a risk factor for
the development of cataracts, leading the group to analyze the
prevalence of cataracts among patients with diabetes taking statins
(n=452) and the prevalence among those taking statins but without
diabetes (n=5884). The mean age of patients with diabetes was 14 years
older than those without diabetes and included a slightly higher
proportion of female subjects. The prevalence of statin use in patients
38 years of age and older was 56% for those with type 2 diabetes and 16%
for those without diabetes.
In the study, known as the Waterloo Eye Study,
diabetes was associated with an 86% higher risk of developing cataracts
(odds ratio [OR] 1.86; 95% CI 1.34-2.59) across the lifespan after
researchers controlled for multiple variables, including age, female
sex, smoking, and blood pressure. A diagnosis of diabetes was also
associated with an increased risk of different subtypes of cataracts: an
84% greater risk of nuclear sclerosis, a 38% higher risk of cortical
cataract, and a 52% rise in posterior subcapsular cataract
Statin use was also associated with a
significantly increased risk of developing age-related cataracts (OR
1.57; 95% CI 1.15-2.13) and some subtypes, including a 48% higher risk
of nuclear sclerosis and a 48% rise in posterior subcapsular cataract
but no increased risk of cortical cataract.
In an analysis of cataract prevalence among
patients with and without diabetes taking statins, Machan and colleagues
found that the prevalence of cataract increased at a faster rate in
patients with diabetes who used statins. "Similar prevalence levels were
seen in patients with diabetes who did not use statins and in patients
without diabetes who did use statins," according to the researchers.
"The prevalence of cataract increased at the slowest rate in patients
without diabetes who did not use statins."
No comments:
Post a Comment